Processing

Please wait...

Settings

Settings

1. WO2015077537 - HETEROARYL-ETHER FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS

Publication Number WO/2015/077537
Publication Date 28.05.2015
International Application No. PCT/US2014/066770
International Filing Date 21.11.2014
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
4353
ortho- or peri-condensed with heterocyclic ring systems
437
the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
A61K 31/437 (2006.01)
CPC
C07D 471/04
Applicants
  • CORCEPT THERAPEUTICS, INC. [US/US]; 149 Commonwealth Drive Menlo Park, California 94025, US
Inventors
  • HUNT, Hazel; GB
  • WALTERS, Iain; GB
  • RAY, Nicholas; GB
Agents
  • TRIMBLE, Alexander R.; US
Priority Data
61/908,25525.11.2013US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) HETEROARYL-ETHER FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
(FR) COMPOSÉS D'AZADÉCALINE FUSIONNÉS HÉTÉROARYLE ÉTHER UTILISÉS EN TANT QUE MODULATEURS DU RÉCEPTEUR DES GLUCOCORTICOÏDES
Abstract
(EN)
The present invention provides heteroaryl ether fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
(FR)
La présente invention concerne des composés azadécaline fusionnés hétéroaryle éther et des méthodes d'utilisation desdits composés en tant que modulateurs du récepteur des glucocorticoïdes.
Latest bibliographic data on file with the International Bureau